InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,841.47
(
-0.02%
)
US TECH 100
19,736.40
(
0.44%
)
Dow Jones
43,239.05
(
0.37%
)
Brent Oil
74.07
(
-0.12%
)
Bitcoin
67,755.16
(
0.50%
)
Post# of 346500
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

nh

Send PM Follow Ignore
Followers 24
Posts 1600
Boards Moderated 0
Alias Born 05/27/2005

nh

Re: peregr post# 272936

Wednesday, 09/21/2016 2:46:26 PM

Wednesday, September 21, 2016 2:46:26 PM

Post# of 346500

And don't overlook this nuance. The Bavi/biomarker beat the docetaxel control arm which was off the charts.



And the standard of care is still in effect, which is lower than the control arm results.

So if patient tests positive for referenced biomarkers, will this become a tx option?
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CDMO News
More CDMO News
InvestorsHub NewsWire

Unitronix Corp Advances DeFi Innovation with Tokenized Real-World Assets Integration • UTRX • Oct 17, 2024 7:38 AM

Mass Megawatts Commences Solar Energy Sales Efforts • MMMW • Oct 16, 2024 7:45 AM

SANUWAVE Health Announces 1-For-375 Reverse Stock Split • SNWV • Oct 16, 2024 7:40 AM

Future Hospitality Ventures Unveils Bold, New AI-Driven Initiative to Revolutionize the $300 Billion Hospitality Market • NGTF • Oct 16, 2024 7:07 AM

Kona Gold Beverages, Inc. Announces Strategic Progress and Corporate Evolution • KGKG • Oct 15, 2024 9:00 AM

One World Products Secures First Order for Hemp-Based Reusable Containers, Pioneers Renewable Materials for the Automotive Industry • OWPC • Oct 15, 2024 8:35 AM

Start posting your company's news
Only $200 per official company press release!